Quantum Biopharma (QNTM) Other Non Operating Income (2019 - 2026)

Quantum Biopharma has disclosed Other Non Operating Income across 8 years of filings, most recently posting $7.0 million for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $7.0 million, up 123.6% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.5 million (down 485.19% YoY), and the FY2025 annual result was -$11.9 million, down 11498.54% from the prior year.
• Other Non Operating Income came in at $7.0 million for Q1 2026 at Quantum Biopharma, up from -$23.8 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $7.0 million in Q1 2026 to a low of -$23.8 million in Q4 2025.
• The 5-year median for Other Non Operating Income is $174001.0 (2023), against an average of -$1.1 million.
• Peak annual rise in Other Non Operating Income reached 1690813.51% in 2025, while the deepest fall reached 17648.14% in 2025.
• Quantum Biopharma's Other Non Operating Income stood at -$1.5 million in 2022, then soared by 113.96% to $212256.0 in 2023, then slumped by 36.05% to $135746.0 in 2024, then plunged by 17648.14% to -$23.8 million in 2025, then soared by 129.2% to $7.0 million in 2026.
• The last three Other Non Operating Income figures came in at $7.0 million (Q1 2026), -$23.8 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.